RECOMBITEK C8This page contains information on RECOMBITEK C8 for veterinary use.
The information provided typically includes the following:
- RECOMBITEK C8 Indications
- Warnings and cautions for RECOMBITEK C8
- Direction and dosage information for RECOMBITEK C8
RECOMBITEK C8This treatment applies to the following species:
Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus Vaccine, Modified Live Virus, Live Canarypox Vector, Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterin
DESCRIPTION: RECOMBITEK® C8 contains a lyophilized suspension of a recombinant canarypox vector expressing the HA and F glycoproteins of canine distemper virus; modified live adenovirus type 2, parainfluenza virus, and parvovirus; and a liquid suspension of Leptospira Canicola, L. Grippotyphosa, L. Icterohaemorrhagiae, and L. Pomona.
INDICATIONS: This product is recommended for the vaccination of healthy dogs 9 weeks of age and older for prevention of disease due to canine distemper virus, canine parvovirus, canine adenovirus type 1 (canine hepatitis), canine adenovirus type 2 (canine respiratory disease complex), canine parainfluenza virus, and for the prevention of leptospirosis and leptospiruria caused by Leptospira Canicola, L. Grippotyphosa and L. Icterohaemorrhagiae, and as an aid in the prevention of leptospirosis and leptospiruria caused by L. Pomona.
DOSAGE: Reconstitute the lyophilized vaccine with accompanying diluent and aseptically inject 1 mL (1 dose) subcutaneously into healthy dogs. For primary vaccination, revaccinate with a second 1 mL dose 3 to 4 weeks later. Revaccination annually with a single 1 mL dose is recommended, although, the revaccination frequency should be determined by the attending veterinarian based on the animal’s age, breed, health status, environment, lifestyle and travel habits. Duration of immunity for L. Grippotyphosa was demonstrated by challenge in dogs to be at least 15 months following vaccination.
PRECAUTIONS: Store at 2-7°C (35-45°F). Do not freeze. Use immediately after reconstitution. Do not use chemicals to sterilize syringes and needles. Burn container and all unused contents. Contains gentamicin as a preservative. This product has not been evaluated in pregnant dogs. In rare instances, administration of vaccines may cause transient pain and swelling at the injection site, lethargy, fever, and inflammatory or hypersensitivity types of reactions. Treatment may include antihistamines, anti-inflammatories, and/or epinephrine, as directed by a veterinarian.
SOLD TO VETERINARIANS ONLY.
For Veterinary Use Only.
RECOMBITEK is a registered trademark of MERIAL.
Manufactured By MERIAL INC., Athens, GA 30601 USA
U.S. Vet. Lic. No. 298
Distributed In Canada By MERIAL CANADA, INC., Baie d’Urfé, Qc, H9X 4B6
25 x 1 Dose, Lyophilized
25 x 1 Dose (1 mL), Liquid
NAC No.: 1111136.1
Merial is now part of Boehringer Ingelheim
3239 SATELLITE BLVD., DULUTH, GA, 30096
|Every effort has been made to ensure the accuracy of the RECOMBITEK C8 information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2018 North American Compendiums. Updated: 2018-02-26